Is a CR really likely? The company might not need a CR.
I wonder what is happening with divestment with hep drug.
An update on the expected divestment income of $2m will be good.
The divestment is ongoing, as per the announcement below. For details:
http://www.asx.com.au/asxpdf/20140114/pdf/42m3mn3z6cqrbq.pdf
Given other products in the portfolio, it does look like a very good buy at this price.
- Market cap about 2.5 m.
- Expected divestment income: 2m
- Other existing high impact products in the portfolio
Is a CR really likely? The company might not need a CR.I wonder...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 34836742 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 7730060 | 9 |
View Market Depth
| Last trade - 16.21pm 29/07/2025 (20 minute delay) ? |
| CT1 (ASX) Chart |
Day chart unavailable